Table 4.
Histogram % gated cells at baseline and after 30 days of using PEG/PG lubricant eyedrops four times daily
| Sample number | % HLA-DR (OD/OS)
|
Days between visits | |
|---|---|---|---|
| Baseline | Day 30 | ||
| 001 | 4.14/2.75 | NA | NA |
| 002 | 3.87/3.12 | 5.05/2.89 | 31 |
| 003 | 9.61/13.17 | NA | NA |
| 004 | 11.07/12.87 | 1.12/2.95 | 34 |
| 005 | 23.21/21.13 | 4.26/0.70 | 34 |
| 006 | 20.88/11.41 | 1.11/1.81 | 28 |
| 007a | 7.31/3.29 | 1.45/2.30 | 36 |
| 008 | 0.58/0.35 | 8.52/8.97 | 43 |
| 009 | 0.64/0.63 | 4.34/4.29 | 26 |
| 010 | 2.02/1.18 | 3.23/2.57 | 32 |
| 011 | 4.60/10.04 | 6.31/5.12 | 24 |
| 012 | 13.61/4.80 | NA | NA |
| 013a | 3.09/5.59 | 1.23/4.96 | 41 |
| 014 | 7.95/17.55 | 3.38/2.78 | 30 |
| 015 | 4.76/12.19 | 2.91/2.59 | 28 |
| 016 | 6.54/7.72 | 3.87/2.40 | 36 |
| 017 | 1.44/2.58 | 1.48/7.17 | 35 |
| 018 | 6.12/3.59 | 4.30/6.65 | 28 |
| 019 | 5.50/1.66 | 5.23/4.76 | 30 |
| Mean ± SD | 7.17±6.10 | 3.77±2.12b | 32±5 |
Notes:
a
Patients receiving Restasis® (cyclosporine A) for >6 months.
b
P=0.0212 versus baseline, paired t-test.
Abbreviations: HLA-DR, human leukocyte antigen D-related; NA, not available; OD, oculus dexter; OS, oculus sinister; PEG, polyethylene glycol; PG, propylene glycol.